Cerulean Pharma reported $8.4M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Arrowhead Research ARWR:US USD 115.4M 10.08M
Bayer BAYN:GR EUR 10.08B 2.57B
Biocept BIOC:US USD 11.16M 4.54M
Brainstorm Cell Therapeutics BCLI:US USD 6.84M 750K
Immunogen IMGN:US USD 92.8M 17.59M
Johnson & Johnson JNJ:US USD 17.97B 211M
Macrogenics MGNX:US USD 66.69M 1.13M
Merk MRK:US USD 10.97B 1.31B
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Perrigo Ordinary Shares PRGO:US USD 1.07B 71.2M
Pfizer PFE:US USD 13.23B 2.41B
Seattle Genetics SGEN:US USD 703.1M 72.49M
YTE INCY:US USD 684.93M 27.96M